Related topics: cancer , cells , breast cancer , cancer cells , immune cells
Journal of Clinical Investigation
hideThe Journal of Clinical Investigation (JCI or J Clin Invest) is a leading biomedical journal, with a 2008 impact factor of 16.559. The journal makes its research articles -- including access to articles back to 1924 -- freely available online.
The website of the journal describes it as "a premier venue for critical advances in biomedical research, authoritative reviews, and commentaries that place research articles in context." The first issue of the journal appeared in 1924, and within a few decades, it had established itself as a reputed journal for primary clinical research.
The JCI's Editorial Board is unique in that its members are located chiefly at a singular academic medical center and are predominantly members of the American Society for Clinical Investigation. The leadership of the Editorial Board changes every five years: As of March 2007, the Editorial Board is located at the University of Pennsylvania under the leadership of Laurence A. Turka, M.D. From March 2002 to March 2007, the Editorial Board was located at Columbia University under the leadership of Andrew Marks, M.D. Ushma S. Neill, formerly with Nature Medicine, is the journal's Executive Editor.
This monthly journal publishes original research and review articles, including periodic review series focusing on important topics in biomedicine.
For more information about Journal of Clinical Investigation, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
News tagged with journal of clinical investigation
Why Some Monkeys Don't Get AIDS
Medicine & Health / HIV & AIDS
Dec 03, 2009 |
not rated yet |
0
(PhysOrg.com) -- Two studies published this month in the Journal of Clinical Investigation provide a significant advance in understanding how some species of monkeys such as sooty mangabeys and African green ...
New understanding of how to prevent destruction of a tumor suppressor
Dec 07, 2009 |
not rated yet |
0
Researchers from the Indiana University School of Medicine and colleagues at the University of Texas Southwestern and Case Western University have determined how the protein Mdm2, which is elevated in late-stage ...
Scientists identify possible therapy target for aggressive cancer
Dec 01, 2009 |
5 / 5 (1) |
0
UT Southwestern Medical Center researchers have found that a naturally occurring protein -- transforming growth factor beta1 (TGF-ß1) -- which normally suppresses the growth of cancer cells, causes a rebound effect after ...
Death-inducing proteins key to complications of bone marrow transplantation
Dec 01, 2009 |
not rated yet |
0
Treatment for a number of cancers and other medical conditions is transplantation with bone marrow from a genetically nonidentical individual (a process known as allogeneic bone marrow transplantation [allo-BMT]).
Search results for journal of clinical investigation
Study shows a key protein helps control blood pressure
Dec 23, 2009 |
4.5 / 5 (2) |
0
University of Iowa researchers have shown that a protein channel helps nerve sensors in blood vessels keep blood pressure in check. Without the protein channel, known as ASIC2, the sensors are unable to send the brain the ...
Gene therapy makes mice breath easier
Dec 21, 2009 |
5 / 5 (1) |
0
Researchers from Boston University School of Medicine (BUSM) have discovered a new gene therapy that may prevent the progression of emphysema. The study, which appears on-line in the Journal of Clinical Investigation, descri ...
About 25 percent of Arabs in Greater Detroit reported abuse post Sept. 11
Other Sciences / Social Sciences
Dec 17, 2009 |
4.7 / 5 (3) |
0
One quarter of Detroit-area Arab Americans reported personal or familial abuse because of race, ethnicity or religion since 9/11, leading to higher odds of adverse health effects, according to a new University of Michigan ...
Videos can help cancer patients choose level of care they prefer
Dec 02, 2009 |
not rated yet |
0
Patients with terminal brain cancer who watched a brief video illustrating options for end-of-life care were significantly more likely to indicate a preference for comfort measures only than were patients who listened to ...
Human Mdm2: A new molecular link to late-stage metastatic breast cancer
Dec 02, 2009 |
not rated yet |
0
A large proportion of late-stage breast cancers that have spread to other parts of the body (metastatic breast cancers) are characterized by overexpression of the protein Mdm2.
High urea levels in chronic kidney failure might be toxic after all
Dec 02, 2009 |
not rated yet |
0
It is thought that the elevated levels of urea (the byproduct of protein breakdown that is excreted in the urine) in patients with end-stage kidney failure are not particularly toxic.
List of search results for journal of clinical investigation
